Connect with us

Technology

Converging at BIO, ACROBiosystems Connects Emerging Innovation Assets with Global Strategic Opportunities

Published

on

SAN DIEGO, July 13, 2026 /PRNewswire/ — Ahead of the BIO International Convention, BIOSeedin Summer Innovation Partnering Summit was successfully held at Wyndham San Diego Bayside, California. Hosted by bioSeedin, the summit’s discussion topics were about early-stage innovation assets, late-stage clinical pipelines, business development strategies, M&A trends, multinational collaboration models, and global licensing transactions.

ACROBiosystems participated as a key strategic partner under the theme “Enabling Global Opportunity,” working with a broad network of industry partners to build a strategic partnering platform for the globalization of innovation assets. The event gathered more than 200 participants from over 30 countries, creating a highly active environment for business dialogue and partnering discussions.

During the summit, ACROBiosystems set up a dedicated networking lounge to provide attendees with an exclusive space for in-depth discussion, helping turn thought leadership and ideas into tangible collaboration.

As innovative drug development becomes increasingly global, ACROBiosystems is further leveraging its global customer network, technical service capabilities, industry insight, and ecosystem connectivity to advance its role as a global strategic partner for innovation. Through the summit, ACROBiosystems aims to amplify the visibility of high-potential innovation assets and help them gain greater international recognition, deeper industry understanding, and more partnering opportunities during a critical window for the global biopharmaceutical industry.

From winter to summer, ACROBiosystems has continued to advance global innovation partnerships. Following the BIOSeedin Winter Innovation Partnering Summit in San Francisco this January and the BIOSeedin Spring Innovation Partnering Summit in Shanghai this May, the BIOSeedin Summer Innovation Partnering Summit in San Diego further extended this momentum. Besides, ACROBiosystems has also hosted ACRO Innovation Day and the ACRO Innovation Forum in Europe and Shanghai, reinforcing its commitment to empowering the industry and building platforms for innovation exchange.

Looking ahead, ACROBiosystems will continue to work with global partners around its core brand values of “Reliable Quality, Integrated Innovation, and Considerate Service”, jointly accelerating the translation of biopharmaceutical innovation into clinical applications and global markets.

Summit Recap

The summit opened with remarks from Ms. Jenny Zhao, Co-founder and CEO of bioSeedin.

And then the summit went on with panels and company presentations, along with one on one partnering session to motivate exchange and precision collaborations.

The panel session split into two parts: the early-stage and late-stage session.

No. 1 Early-Stage Session

The Early-Stage Session featured two panel discussions on licensing, external innovation, and M&A. The first panel brought together executives from Debiopharm, Otsuka Pharmaceutical, Roche/Genentech, AstraZeneca.

Key Takeaways:

Licensing is not simply an asset transaction, but a strategic tool for translating differentiated science into long-term value.Strong biology, high-quality data, translational continuity, and a credible global clinical development plan remain essential to deal execution.Deals often stall due to weak biological rationale, unclear patient or biomarker strategies, poor PK/PD or therapeutic windows, and inadequate global development planning.

The second panel was moderated by Kenneth C. Chen, Senior Director of Business Development, US & EU, at bioSeedin, and featured executives from Sun Pharma, Hygieia Pharma, and Servier.

Key Takeaways:

M&A should support long-term corporate strategy rather than serve as an end goal.Companies need to balance acquisitions, strategic investments, and licensing transactions.Successful M&A depends on valuation discipline, rigorous due diligence, effective execution, and post-deal integration.

The session also included company presentations from Antengene, GeneScience Pharmaceutical, and Salsola Therapeutics, showcasing innovative pipelines across autoimmune diseases, immunology, and neuropsychiatric disorders.

No. 2 Late-Stage Session

The Late-Stage Session Executives from Daiichi Sankyo, Takeda, Boehringer Ingelheim, and Thermo Fisher Scientific discussed the global innovation ecosystem and emerging industry trends.

Key Takeaways:

Innovation must remain grounded in strong science, robust biology, high-quality data, and rigorous R&D.

China and AI are long-term structural forces rather than short-term trends. Companies need a clear and coherent China strategy.

AI can support the full R&D value chain, but it cannot replace scientific fundamentals.

The session also featured presentations from HighTide Therapeutics, Constimulus Bio, CanWell Pharma, Jiangsu Chia Tai Fenghai Pharmaceutical, Amphiprotech, and VyBio, showcasing advanced pipelines and global development opportunities across multiple therapeutic areas.

About ACROBiosystems Group:

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and healthcare industries by providing innovative products and business models. The company spans across the globe and maintains offices, R&D centers, and production bases in more than 15 different cities within the United States, Switzerland, the United Kingdom and Germany. ACROBiosystems Group has established numerous long-term and stable partnerships with the world’s top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes. The company comprises several subsidiaries such as ACROBiosystems, bioSeedin, Condense Capital, and ACRODiagnostics.

ACROBiosystems’ brands include Resilient Supply, CytoPak, SAFENSURE, FLAG, Star Staining, Aneuro, ComboX, GENPower and many others. Its main products and services are recombinant proteins, kits, antibodies, scientific services, and other related products. ACROBiosystems employs a strict quality control system for its products that are used in biopharmaceutical research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics.

Through the continuous development of new technologies and products, ACROBiosystems Group creates value for the global pharmaceutical industry and actively empowers our partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapeutic drugs, and their clinical applications, and contributes to global health.

View original content to download multimedia:https://www.prnewswire.com/news-releases/converging-at-bio-acrobiosystems-connects-emerging-innovation-assets-with-global-strategic-opportunities-302823630.html

SOURCE ACROBiosystems

Continue Reading

Technology

ISC2 AI Security Academy Builds Cybersecurity Professionals’ AI Security Skills

Published

on

By

Three learning tracks enable cybersecurity professionals to focus
on their AI security responsibilities and professional goals

ALEXANDRIA, Va., Nov. 16, 2026 /PRNewswire/ — ISC2 – the world’s leading nonprofit member organization for cybersecurity professionals – today launched the ISC2 AI Security Academy, a structured professional development framework designed to help cybersecurity professionals build practical capabilities for securing AI-enabled environments. The Academy features clear learning pathways — including certificates, courses and workshops — that are mapped to three learning tracks, each focused on a different set of AI security responsibilities.

As AI changes governance, risk management, security operations, software security and more, cybersecurity professionals need ongoing, role-relevant AI security learning to keep up with the pace of change. According to the latest ISC2 Cybersecurity Workforce Study, 41% of participants who said their organization’s security team had at least one skill need cited AI skills as the most pressing need.

“Understanding AI’s opportunities and risks is only a starting point. Professionals need relevant AI security learning they can put to work in their own roles,” said Casey Marks, Ph.D., ISC2 Chief Operations Officer. “The Academy gives them a place to start that reflects their responsibilities and experience. Rather than following the same path, cybersecurity professionals can tailor their AI security development to build on what they have already learned and continue developing skills as roles evolve.”

Three Tracks of Practical AI Security Training

The Academy brings together professional development across three areas:

AI Security Foundations is for professionals who need a working understanding of AI security as it relates to their work.AI Security Practitioner is for professionals who apply hands-on AI security in their day-to-day work.AI Security Leader focuses on AI security decision-making and applying it across an organization.

The framework supports a shared understanding of AI security while providing increasing depth aligned to professional responsibility and decision authority, covering the following topics:

Governance & Compliance addresses subjects such as AI governance architecture, policy mapping, regulatory change and AI data governance.Risk Management includes AI-driven data discovery, enterprise risk aggregation, controls monitoring, bias and model assurance, and AI risk assessment.Security Operations focuses on areas including AI-driven penetration testing, AI-augmented incident response, AI-assisted threat detection and network analysis.Software Security incorporates topics such as DevSecOps, SAST and DAST, AI-powered code completion and repair, threat-to-requirement mapping and secure software architecture with AI.

New learning opportunities are continually added to the Academy’s portfolio, giving cybersecurity practitioners and leaders ongoing opportunities to add to their skills base and expertise.

A Commitment to Skilling the Cybersecurity Workforce for AI

The Academy is an important step in ISC2’s commitment to give its members and the broader cybersecurity community the resources and skills they need to succeed in the age of AI. Over the past year, ISC2 has expanded the courses, workshops, webinars and research available to its members.

Earlier this year, ISC2 also released Exam Guidance for Artificial Intelligence to show how AI-related skills connect to its certifications. ISC2 is also in the final phase of developing an AI security certification, shaped by nearly 12,000 volunteers worldwide. The pilot exam outline is now available, and 3,000 volunteers will be invited to take the pilot exam later this year. Alongside these efforts, ISC2 has established the Cyber-AI Workforce Coalition to define how cybersecurity roles will evolve in the AI era.

For more information, visit the ISC2 AI Security Academy.

About ISC2

ISC2 is the world’s leading member organization for cybersecurity professionals, driven by our vision of a safe and secure cyber world. Our more than 270,000 certified members, and associates, are a force for good, safeguarding the way we live. Our award-winning certifications – including cybersecurity’s premier certification, the CISSP® – enable professionals to demonstrate their knowledge, skills and abilities at every stage of their careers. ISC2 strengthens the influence, diversity and vitality of the cybersecurity profession through advocacy, expertise and workforce empowerment that accelerates cyber safety and security in an interconnected world. Our charitable foundation, the Center for Cyber Safety and Education, helps create more access to cyber careers and educates those most vulnerable. Learn more, get involved or become an ISC2 Candidate to build your cyber career at ISC2.org. Connect with us on X, Facebook and LinkedIn.

© 2026 ISC2 Inc., ISC2, CISSP, SSCP, CCSP, CGRC, CSSLP, HCISPP, ISSAP, ISSEP, ISSMP, CC, and CBK are registered marks of ISC2, Inc.

Media Contact:
Amanda Maguire
Senior Manager, Corporate Communications & PR
ISC2
communications@isc2.org

View original content:https://www.prnewswire.com/news-releases/isc2-ai-security-academy-builds-cybersecurity-professionals-ai-security-skills-302940771.html

SOURCE ISC2

Continue Reading

Technology

Ainstein Opens Kansas Production Facility to Meet Growing Global Demand for Advanced Radar Sensors

Published

on

By

New Lenexa facility adds domestic manufacturing capacity for 44,000 radars annually.

LENEXA, Kan., Nov. 16, 2026 /PRNewswire/ — Ainstein, a global radar sensor and solutions company, opened its new manufacturing facility in Lenexa, Kansas, on Friday with a ribbon-cutting ceremony. The expansion marks a significant milestone in the company’s growth strategy and brings new production capacity to Kansas, where Ainstein was founded in 2015.

Ainstein’s new Lenexa facility adds domestic manufacturing capacity for 44,000 radars annually to meet growing demand.

As demand for radar sensing grows across autonomous vehicles, unmanned systems, and commercial applications, customers require higher capacity, shorter lead times, a more resilient supply chain, and the ability to scale. Ainstein built the Lenexa facility to meet that demand, adding capacity for 44,000 radar sensors a year as the first of many steps in its strategic investment in long-term production capabilities.

Ainstein develops advanced radar sensors for aerospace, specialty and commercial vehicle, professional sports, and emerging technology markets. With over 150,000 sensors deployed worldwide, its radars provide safety and autonomy functions for unmanned aircraft, construction vehicles, agricultural equipment, and commercial fleets.

“We started Ainstein in Lawrence eleven years ago with a small team of engineers and a conviction about what radar could do,” said Dr. Zongbo Wang, Founder and CEO of Ainstein. “Today our radars support autonomy in the air and on the ground in over 40 countries. This facility is the next chapter in Ainstein’s growth strategy. It allows us to continue expanding our production to meet rising global demand and the long-term commitments we have made to our customers, and we are proud to be doing that in Kansas, where it all started.”

The new facility adds a high-tech sensor manufacturer to the state’s aerospace and manufacturing base. It also strengthens domestic supply for critical systems at a time when unmanned aircraft programs increasingly require locally produced sensors at volume. The added U.S. capacity gives Ainstein more room to support customer program and fleet growth while reinforcing its commitment to high-volume manufacturing and investment in Kansas.

The ribbon-cutting ceremony on November 13 welcomed employees, board members, business leaders, community representatives, and partners to the new facility for remarks and tours.

For more information about Ainstein’s radar technology, engineering capabilities, and partnership opportunities, visit https://ainstein.ai.

About Ainstein

Founded in Lawrence, Kansas, in 2015, Ainstein is a global leader in millimeter-wave radar sensing solutions for aerospace, automotive, and industrial markets. Combining deep radar engineering expertise, application-specific development, and dedicated technical support, Ainstein delivers advanced sensing technologies that help OEMs, government contractors, and systems integrators improve safety, efficiency, and autonomy across their products and platforms. Backed by Doosan Bobcat, Ainstein is headquartered in Lawrence, Kansas, with a production facility in Lenexa, Kansas.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ainstein-opens-kansas-production-facility-to-meet-growing-global-demand-for-advanced-radar-sensors-302940786.html

SOURCE Ainstein

Continue Reading

Technology

Turkish Engineer Who Cracked Wall Street’s Algorithm Launches Hermes AI Analyzer

Published

on

By

One score and a council of AI traders that shows its work, now on iPhone and Android.

SANTA CLARA, Calif., Nov. 16, 2026 /PRNewswire/ — Hermes Intelligence Labs, Inc. today announced the worldwide release of Hermes AI Analyzer on the App Store and Google Play. The platform is the work of founder and CEO Umut Tugrul, a software engineer with 26 years in the field, who spent four years and thousands of backtests turning institutional-style market analysis into something a phone can explain in one sentence.

Built as an AI investing app for stock and crypto analysis, Hermes AI Analyzer brings the methods of algorithmic trading to everyday AI market analysis. It answers in plain language, with no indicators to configure and no lines to draw.

The architecture, in plain terms:

DNA Score: a single 0-100 reading for every stock, ETF, index, commodity and cryptocurrency, decomposed into five independent meters.AI Oracle: ten specialist AI traders direct one hundred AI agents through 10,000 trade simulations of the same chart. The council’s vote is shown openly, including its disagreements.Charts: one price read across five horizons at once, with a written interpretation.Hot Dips: a daily scan of every market for declines worth a second look.Hermes Portfolio: a public $1,000 simulation track record, one selected trade a day, with every position since January 2026 published in the app.Reports: DNA, Charts and AI Oracle readings export as PDF reports.

Coverage spans twelve markets across the US, Europe and Asia, plus commodities and crypto, in eleven languages.

“Markets are not complicated because people are not smart enough. They are complicated because the tools were built for specialists. My goal was to keep the depth of the analysis and remove the vocabulary,” said Umut Tugrul, founder and CEO of Hermes Intelligence Labs, Inc.

Availability: Hermes AI Analyzer is free to download on iPhone and Android, with 2 free analyses a day and 25 welcome credits on first launch. No subscription, no ads; credit packs are one-time purchases.

About Umut Tugrul: a software engineer and systems architect with 26 years of experience, from high-volume commerce infrastructure at GittiGidiyor (eBay Turkey) to security engineering, and for the last nine years blockchain and artificial intelligence.

Download:
App Store: https://apps.apple.com/app/id6826131056
Google Play: https://play.google.com/store/apps/details?id=com.hermesaianalyzer.app

Follow Hermes AI Analyzer:
Instagram: https://www.instagram.com/hermes_ai_app/
Telegram: https://t.me/hermes_ai_app
Umut Tugrul on LinkedIn: https://www.linkedin.com/in/umut-tugrul-1147b0372/
Web: https://www.hermesaianalyzer.com

Hermes AI Analyzer does not provide investment advice. Scores and AI Oracle readings are algorithmic, reflect historical price behavior only and can be wrong. Hermes Portfolio is a simulation.

Media Contact:
Umut Tugrul, Hermes Intelligence Labs, Inc.
hi@hermesaianalyzer.com

Photo(s):
https://www.prlog.org/13183325

Press release distributed by PRLog

View original content:https://www.prnewswire.com/news-releases/turkish-engineer-who-cracked-wall-streets-algorithm-launches-hermes-ai-analyzer-302940642.html

SOURCE Hermes Intelligence Labs, Inc.

Continue Reading

Trending